©The Author(s) 2025.
World J Gastrointest Oncol. Dec 15, 2025; 17(12): 112761
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.112761
Published online Dec 15, 2025. doi: 10.4251/wjgo.v17.i12.112761
Table 2 General analysis of two groups of non-alcoholic fatty liver disease patients, n (%)
| Qinghai NAFLD group (n = 585) | Tianjin NAFLD group (n = 91) | P value | |
| BMI | 25.4 (23.7, 27.4) | 27.48 (24.65, 29.07) | < 0.001 |
| Drinking history | 151 (25.8) | 33 (36.3) | 0.037 |
| Smoking history | 178 (30.4) | 27 (29.7) | 0.884 |
| Hypertension disease | 162 (27.7) | 35 (38.5) | 0.035 |
| Diabetes | 95 (16.2) | 17 (18.7) | 0.56 |
| Coronary heart disease | 19 (3.4) | 6 (6.8) | 0.08 |
- Citation: Wang CY, Ma L, Zhao Y, Zhang XJ, Li S, Liu YG, Guo HM, Qi JG, Wang JQ, Ye WX, Li JZ, Zhang T. Clinical characteristics of colorectal polyps in patients with non-alcoholic fatty liver disease in high altitude areas. World J Gastrointest Oncol 2025; 17(12): 112761
- URL: https://www.wjgnet.com/1948-5204/full/v17/i12/112761.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i12.112761